# Church & Dwight Co Inc: Form 10-Q for the period ended Jun 30, 2019

- Company: [Church & Dwight Co Inc](/companies/chd.md) (CIK 313927)
- Form: 10-Q
- Filed: 2019-07-31
- Accepted by EDGAR: Jul 31, 2019, 16:52 ET
- Period: 2019-06-30
- Accession: 0001564590-19-027342
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/313927/000156459019027342/chd-10q_20190630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/313927/000156459019027342/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-04-01 to 2019-06-30 | $1.08bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2019-01-01 to 2019-06-30 | $2.12bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2019-04-01 to 2019-06-30 | $597.9m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2019-01-01 to 2019-06-30 | $1.17bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2019-04-01 to 2019-06-30 | $481.5m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2019-01-01 to 2019-06-30 | $952.3m | us-gaap:GrossProfit |
| Research and development | 3 months, 2019-04-01 to 2019-06-30 | $22.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2019-01-01 to 2019-06-30 | $43.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2019-04-01 to 2019-06-30 | $165.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2019-01-01 to 2019-06-30 | $296.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2019-04-01 to 2019-06-30 | $187.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2019-01-01 to 2019-06-30 | $428.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2019-04-01 to 2019-06-30 | $18.9m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2019-01-01 to 2019-06-30 | $36.7m | us-gaap:InterestExpense |
| Income tax | 3 months, 2019-04-01 to 2019-06-30 | $31.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2019-01-01 to 2019-06-30 | $81.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-04-01 to 2019-06-30 | $138.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2019-01-01 to 2019-06-30 | $314.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-04-01 to 2019-06-30 | $0.55 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2019-01-01 to 2019-06-30 | $1.25 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-04-01 to 2019-06-30 | $0.56 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2019-01-01 to 2019-06-30 | $1.28 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-04-01 to 2019-06-30 | 252,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2019-01-01 to 2019-06-30 | 252,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2019-01-01 to 2019-06-30 | $351.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2019-01-01 to 2019-06-30 | $23.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2019-01-01 to 2019-06-30 | $112.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months, 2019-01-01 to 2019-06-30 | $100.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2019-06-30 | $97.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-06-30 | $925.9m | us-gaap:AssetsCurrent |
| Total assets | at 2019-06-30 | $6.66bn | us-gaap:Assets |
| Current liabilities | at 2019-06-30 | $1.18bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-06-30 | $4.06bn | us-gaap:Liabilities |
| Long-term debt | at 2019-06-30 | $1.81bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2019-06-30 | $299.0m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2019-06-30 | $111.6m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2019-06-30 | $2.60bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 28,384 characters.

#### Recent Developments

#### Flawless Acquisition

On May 1, 2019, we closed on our previously announced acquisition of the FLAWLESS™ and FINISHING TOUCH™ hair removal business (“Flawless” and the acquisition, the “Flawless Acquisition”) from Ideavillage Products Corporation (“Ideavillage”). We paid $475.0 at closing and will make an additional earn-out payment up to a maximum of $425.0 in cash, based on a trailing twelve-month net sales target ending no later than December 31, 2021. The transaction was funded with a three-year term loan and commercial paper borrowings. We anticipate there will be a five-month integration transition period in which the net cash received from Ideavillage will be accounted for as other revenue as a component of net sales. We will purchase the inventory following the transition period. FLAWLESS is managed in the Consumer Domestic and Consumer International segments and represents an addition to our specialty haircare portfolio which includes BATISTE dry shampoo, VIVISCAL hair thinning supplements, and TOPPIK hair fibers. Ideavillage will help support the business through a separate long-term transition services agreement.

#### Amended Credit Agreement

On May 1, 2019, we amended our $1,000.0 unsecured revolving credit facility (the “Credit Agreement”) to extend the term of the Credit Agreement from March 29, 2023 to March 29, 2024. Under the Credit Agreement, we continue to have the ability to increase our borrowing up to an additional $600.0, subject to lender commitments and certain conditions as described in the Credit Agreement. Borrowings under the Credit Agreement are available for general corporate purposes and are used to support our $1,000.0 commercial paper program.

#### Term Loan

On May 1, 2019, we entered into a $300.0 unsecured term loan credit facility with various banks, the proceeds of which were used to partially fund the Flawless Acquisition. Unless prepaid, the loan is due on May 1, 2022. The interest rate is LIBOR plus an applicable margin based on our credit rating, which can range from 60 basis points (“bps”) to 113 bps.

#### Brazil’s Consumer Business

During the second quarter of 2019, we decided to sell and subsequently sold our Brazilian consumer business, resulting in a $7.6 ($0.03 diluted per share) charge recorded in SG&A expense for severance, asset write-offs, and other charges. Net sales for the Brazilian consumer business in 2018 were approximately $15.0 in the Consumer International segment.

### Results of Operations

### Consolidated results

|  | Three Months Ended June 30, 2019 | Change vs. Prior Year | Three Months Ended June 30, 2018 |
| --- | ---: | ---: | ---: |
| **Net Sales** | **$1,079.4** | 5.0% | $1,027.9 |
| **Gross Profit** | **$481.5** | 5.8% | $454.9 |
| Gross Margin | **44.6%** | +30 basis points | 44.3% |
| **Marketing Expenses** | **$129.1** | -5.4% | $136.4 |
| Percent of Net Sales | **12.0%** | -130 basis points | 13.3% |
| **Selling, General & Administrative Expenses** | **$165.0** | 14.0% | $144.7 |
| Percent of Net Sales | **15.3%** | +120 basis points | 14.1% |
| **Income from Operations** | **$187.4** | 7.8% | $173.8 |
| Operating Margin | **17.3%** | +40 basis points | 16.9% |
| **Net income per share - Diluted** | **$0.55** | 12.2% | $0.49 |
|  | **Six Months Ended** | **Change vs.** | **Six Months Ended** |
|  | **June 30, 2019** | **Prior Year** | **June 30, 2018** |
| **Net Sales** | **$2,124.1** | 4.4% | $2,033.9 |
| **Gross Profit** | **$952.3** | 5.1% | $906.4 |
| Gross Margin | **44.8%** | +20 basis points | 44.6% |
| **Marketing Expenses** | **$227.2** | -3.9% | $236.3 |
| Percent of Net Sales | **10.7%** | -90 basis points | 11.6% |
| **Selling, General & Administrative Expenses** | **$296.9** | 7.6% | $276.0 |
| Percent of Net Sales | **14.0%** | +40 basis points | 13.6% |
| **Income from Operations** | **$428.2** | 8.7% | $394.1 |
| Operating Margin | **20.1%** | +70 basis points | 19.4% |
| **Net income per share - Diluted** | **$1.25** | 11.6% | $1.12 |

Diluted Net Income per share was $0.55 in the second quarter of 2019 as compared to $0.49 in the second quarter of 2018. Diluted Net Income per share was $1.25 in the first six months of 2019 as compared to $1.12 in the same period in 2018. During the second quarter of 2019, we decided to sell and subsequently sold our consumer business in Brazil, and recorded a pre- and post- tax charge of $7.6 ($0.03 diluted per share) in selling and general administrative expenses. During the second quarter of 2019, we increased the estimate of the contingent liability by $5.0 ($3.7 after tax or $0.01 diluted per share) associated with the Flawless Acquisition and reversed the full contingent liability of $7.3 ($5.5 after tax or $0.02 diluted per share) associated with the acquisition of Passport Food and Safety Solutions, Inc. (“Passport,” and the acquisition, the “Passport Acquisition”), based on updated sales forecasts. Both contingent liability adjustments were recorded in SG&A expense.

#### Net Sales

Net sales for the quarter ended June 30, 2019 were $1,079.4, an increase of $51.5 or 5.0% as compared to the same period in 2018. Net sales for the six months ended June 30, 2019 were $2,124.1, an increase of $90.2 or 4.4% over the comparable six month period of 2018. The components of the net sales increase are as follows:

| Net Sales - Consolidated | Three Months Ended June 30, 2019 | Six Months Ended June 30, 2019 |
| --- | ---: | ---: |
| Product volumes sold | 0.1% | 1.2% |
| Pricing/Product mix | 4.8% | 3.5% |
| Foreign exchange rate fluctuations | (0.6%) | (0.8%) |
| Acquired product lines (1) | 0.7% | 0.5% |
| **Net Sales increase** | **5.0%** | **4.4%** |

(1) On March 8, 2018, we completed the Passport Acquisition. On May 1, 2019, we completed the Flawless Acquisition. The results of these acquisitions are included in our results since the date of acquisition.

For the three months ended June 30, 2019, the volume change primarily reflects increased product sales in the Consumer International segment, with volume declines in Specialty Products (“SPD”) and Consumer Domestic segments. For the six months ended June 30, 2019, the volume change primarily reflects increased product sales in the Consumer International segment, with volume declines in SPD, while Consumer Domestic volumes remained unchanged. For the three months ended June 30, 2019, price/mix was favorable in all three segments. For the six months ended June 30, 2019, favorable price/mix in the Consumer Domestic and SPD segments was partially offset by unfavorable price/mix in the Consumer International segment.

#### Gross Profit / Gross Margin

Our gross profit was $481.5 for the three months ended June 30, 2019, a $26.6 increase as compared to the same period in 2018. Gross margin increased 30 basis points (“bps”) in the second quarter of 2019 compared to the same period in 2018, primarily due to favorable price/volume mix of 230 bps, productivity programs of 130 bps, the impact of higher margins on acquired businesses of 40 bps, partially offset by manufacturing cost increases of 290 bps (including tariffs) and higher commodity and transportation costs of 80 bps. Gross profit was $952.3 for the six months ended June 30, 2019, a $45.9 increase compared to the same period of 2018. Gross margin increased 20 bps in the first six months of 2019 compared to the same period in 2018, primarily due to favorable price/volume mix of 150 bps, productivity programs of 130 bps, the impact of higher margins on acquired businesses of 20 bps, partially offset by manufacturing cost increases of 190 bps (including tariffs) and higher commodity and transportation costs of 90 bps.

#### Operating Expenses

Marketing expenses for the three months ended June 30, 2019 were $129.1, a decrease of $7.3 or 5.4% as compared to the same period in 2018. Marketing expenses as a percentage of net sales in the second quarter of 2019 decreased by 130 bps to 12.0% as compared to 13.3% in the same period in 2018 due to 70 bps on lower expenses and 60 bps of leverage on higher net sales. Marketing expenses for the six months ended June 30, 2019 were $227.2, a decrease of $9.1 or 3.9% as compared to the same period in 2018. Marketing expenses as a percentage of net sales for the first six months of 2019 decreased by 90 bps to 10.7% as compared to 11.6% in the same period in 2018 due to 50 bps of leverage on higher net sales and 40 bps on lower expenses.

Selling, general and administrative (“SG&A”) expenses were $165.0 in the second quarter of 2019, an increase of $20.3 or 14.0% as compared to the same period in 2018. SG&A as a percentage of net sales increased 120 bps to 15.3% in the second quarter of 2019 as compared to 14.1% in the same period in 2018. The increase is due to 190 bps on higher expenses, partially offset by 70 bps of leverage associated with higher sales. SG&A for the first six months of 2019 was $296.9, an increase of $20.9 or 7.6% as compared to the same period in 2018. SG&A as a percentage of net sales increased 40 bps to 14.0% in the first six months of 2019 compared to 13.6% in 2018 due to 100 bps on higher expenses, partially offset by 60 bps of leverage associated with higher sales. The increase for both the three and six month periods ended June 30, 2019 is primarily due to transition and ongoing acquisition-related costs (including the $5.0 Flawless earnout adjustment) and the charge associated with selling our consumer business in Brazil of $7.6, partially offset by the reversal of a $7.3 contingent consideration liability associated with the Passport Acquisition.

#### Other Income and Expenses

Other expense, net for the three and six months ended June 30, 2019 decreased $0.6 and $2.6 respectively, compared to the same period in 2018 primarily due to the effect of changes in foreign exchange rates.

Interest expense for the three and six months ended June 30, 2019 decreased $1.3 and $3.6 respectively, as compared to the same period in 2018 primarily due to the repayment of the $300.0 Floating Rate Senior Notes that matured on January 25, 2019 and lower commercial paper borrowings in 2019 as compared to the same period in 2018. This was partially offset by interest on the $300.0 unsecured term loan credit facility entered into on May 1, 2019.

#### Income Taxes

The effective tax rate for the three and six months ended June 30, 2019 was 18.7% and 20.5% respectively, compared to 21.7% and 21.5% in the same periods in 2018. The decrease in the tax rate for both periods is primarily due to a higher tax benefit on a higher amount of stock option exercises.

### Segment results

We operate three reportable segments: Consumer Domestic, Consumer International and SPD. These segments are determined based on differences in the nature of products and organizational and ownership structures. We also have a Corporate segment.

| Segment | Products |
| --- | --- |
| Consumer Domestic | Household and personal care products |
| Consumer International | Primarily personal care products |
| SPD | Specialty chemical products |

The Corporate segment income consists of equity in earnings of affiliates. As of June 30, 2019, we held 50% ownership interests in each of Armand Products Company (“Armand”) and The ArmaKleen Company (“ArmaKleen”), respectively. Our equity in earnings of Armand and ArmaKleen for the three and six months ended June 30, 2019 and 2018 are included in the Corporate segment. Certain subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth below.

Segment net sales and income before income taxes for the three and six months ended June 30, 2019 and June 30, 2018 are as follows:

| Net Sales(1) | Consumer Domestic | Consumer International | SPD | Corporate | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| **Second Quarter 2019** | **$819.3** | **$186.6** | **$73.5** | **$0.0** | **$1,079.4** |
| Second Quarter 2018 | 774.1 | 176.1 | 77.7 | 0.0 | 1,027.9 |
| **First Six Months of 2019** | **$1,604.2** | **$373.3** | **$146.6** | **$0.0** | **$2,124.1** |
| First Six Months of 2018 | 1,525.5 | 356.8 | 151.6 | 0.0 | 2,033.9 |
| **Income before Income Taxes(2)** |  |  |  |  |  |
| **Second Quarter 2019** | **$136.2** | **$16.9** | **$15.5** | **$1.7** | **$170.3** |
| Second Quarter 2018 | 119.4 | 18.0 | 15.6 | 2.4 | 155.4 |
| **First Six Months of 2019** | **$318.9** | **$45.3** | **$27.8** | **$3.4** | **$395.4** |
| First Six Months of 2018 | 278.7 | 45.7 | 27.2 | 4.5 | 356.1 |

(1) Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $2.4 and $1.7 for the three months ended June 30, 2019 and June 30, 2018, respectively, and were $4.7 and $2.6 for the six months ended June 30, 2019 and June 30, 2018, respectively.

(2) In determining Income before Income Taxes, interest expense, investment earnings and certain aspects of other income and expense were allocated among the segments based upon each segment’s relative Income from Operations.

Product line revenues from external customers are as follows:

|  | Three Months Ended June 30, 2019 | June 30, 2018 | Six Months Ended June 30, 2019 | June 30, 2018 |
| --- | ---: | ---: | ---: | ---: |
| Household Products | **$464.3** | $429.9 | **$907.6** | $842.9 |
| Personal Care Products | **355.0** | 344.2 | **696.6** | 682.6 |
| Total Consumer Domestic | **819.3** | 774.1 | **1,604.2** | 1,525.5 |
| Total Consumer International | **186.6** | 176.1 | **373.3** | 356.8 |
| Total SPD | **73.5** | 77.7 | **146.6** | 151.6 |
| **Total Consolidated Net Sales** | **$1,079.4** | $1,027.9 | **$2,124.1** | $2,033.9 |

Household Products include laundry, deodorizing, and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care and hair care products and gummy dietary supplements.

### Consumer Domestic

Consumer Domestic net sales in the second quarter of 2019 were $819.3, an increase of $45.2 or 5.8% as compared to the same period in 2018. Consumer Domestic net sales for the six months ended June 30, 2019 were $1,604.2 an increase of $78.7 or 5.2% as compared to the same period in 2018. The components of the net sales change are the following:

| Net Sales - Consumer Domestic | Three Months Ended June 30, 2019 | Six Months Ended June 30, 2019 |
| --- | ---: | ---: |
| Product volumes sold | (0.9%) | 0.0% |
| Pricing/Product mix | 5.9% | 4.7% |
| Acquired product lines (1) | 0.8% | 0.5% |
| **Net Sales increase** | **5.8%** | **5.2%** |

(1) Includes the Flawless Acquisition since the date of acquisition.

The increase in net sales for the three months ended June 30, 2019, reflects higher sales of ARM & HAMMER liquid detergent, ARM & HAMMER clumping cat litter, WATERPIK oral care products, OXICLEAN stain fighters, VITAFUSION gummy vitamins, XTRA liquid laundry detergent, ARM & HAMMER scent booster, and BATISTE dry shampoo. The increase in net sales for the six month period ending June 30, 2019, reflects higher sales of ARM & HAMMER liquid detergent, ARM & HAMMER clumping cat litter, WATERPIK oral care products, OXICLEAN stain fighters, XTRA liquid laundry detergent, ARM & HAMMER scent booster, and BATISTE dry shampoo.

There continues to be significant product competition in the gummy vitamin category. The category has grown from eight competitors to 30 in the last five years. We continue to evaluate and vigorously combat these pressures through, among other things, new product introductions and increased marketing and trade spending. However, there is no assurance this category will not decline in the future and that we will be able to offset any such decline.

Consumer Domestic income before income taxes for the second quarter of 2019 was $136.2, a $16.8 increase as compared to the second quarter of 2018. The increase is due primarily to favorable price/mix of $44.9 and lower marketing expenses of $7.0, partially offset by higher SG&A costs of $17.4, unfavorable manufacturing and distribution costs of $14.2 and lower volumes of $4.2. For the six month period ended June 30, 2019, income before income taxes was $318.9, a $40.2 increase as compared to the first six months of 2018. The increase is due primarily to favorable price/mix of $63.9, lower marketing expenses of $11.3 and lower interest and other expenses of $3.7, partially offset by unfavorable manufacturing and distribution costs of $19.6, higher SG&A costs of $16.4 and lower volumes of $2.8.

### Consumer International

Consumer International net sales were $186.6 in the second quarter of 2019, an increase of $10.5 or 6.0% as compared to the same period in 2018. Consumer International net sales in the first six months of 2019 were $373.3, an increase of $16.5 or approximately 4.6% as compared to the same period in 2018. The components of the net sales change are the following:

| Net Sales - Consumer International | Three Months Ended June 30, 2019 | Six Months Ended June 30, 2019 |
| --- | ---: | ---: |
| Product volumes sold | 7.8% | 9.0% |
| Pricing/Product mix | 1.3% | (0.2%) |
| Foreign exchange rate fluctuations / Other | (3.8%) | (4.5%) |
| Acquired product lines (1) | 0.7% | 0.3% |
| **Net Sales increase** | **6.0%** | **4.6%** |

(1) Includes the Flawless Acquisition since the date of acquisition.

Excluding the impact of foreign exchange rates and the Flawless Acquisition, higher sales in the second quarter ended June 30, 2019 were driven primarily by VITAFUSION and L’IL CRITTERS gummy vitamins, STERIMAR, and ARM & HAMMER baking soda in the Global Markets Group business, BATISTE in the U.K., ARM & HAMMER liquid laundry detergent, STERIMAR, and ARM & HAMMER toothpaste in Mexico. WATERPIK sales grew across the Global Markets Group, Canada, U.K., Australia, and

France. For the six months ended June 30, 2019 higher sales were driven primarily by VITAFUSION & L’IL CRITTERS gummy vitamins, FEMFRESH, STERIMAR, and BATISTE in the Global Markets Group business, ARM & HAMMER cat litter and liquid laundry detergent, TROJAN and VITAFUSION & L’IL CRITTERS gummy vitamins in Canada, ANUSOL and BATISTE in the U.K., and ARM & HAMMER liquid laundry detergent and STERIMAR in Mexico. For the six months ended June 30, 2019, WATERPIK sales grew across the Global Markets Group business, U.K., Canada, Australia, and France.

Consumer International income before income taxes was $16.9 in the second quarter of 2019, a decrease of $1.1 compared to the same period in 2018 due primarily to higher SG&A costs of $11.6, unfavorable manufacturing costs of $3.2, higher marketing expenses of $1.0, and unfavorable foreign exchange rates of $0.9, partially offset by higher sales volumes of $7.7 and favorable price/mix of $6.8. For the first six months of 2019, income before income taxes was $45.3, a $0.4 decrease as compared to the same period in 2018, due primarily to higher SG&A costs of $12.7, unfavorable manufacturing costs of $5.7, higher marketing expenses of $4.8, and unfavorable foreign exchange rates of $2.4, partially offset by higher sales volumes of $18.1 and favorable price/mix of $5.2. The higher SG&A costs for both the three and six months include the $7.6 charge associated with the sale of the Consumer business in Brazil.

### Specialty Products (“SPD”)

SPD net sales were $73.5 in the second quarter of 2019, a decrease of $4.2 or 5.4% as compared to the same period in 2018. SPD net sales were $146.6 for the first six months of 2019, a decrease of $5.0, or 3.3% as compared to the same period of 2018. The components of the net sales change are the following:

| Net Sales - SPD | Three Months Ended June 30, 2019 | Six Months Ended June 30, 2019 |
| --- | ---: | ---: |
| Product volumes sold | (6.7%) | (5.6%) |
| Pricing/Product mix | 1.3% | 0.8% |
| Acquired product lines (1) | 0.0% | 1.5% |
| **Net Sales increase** | **(5.4%)** | **(3.3%)** |

(1) Includes net sales of Passport since the date of acquisition.

Excluding the impact of the acquisition, the net sales decrease in the second quarter and six month period of 2019 was driven by lower volumes in the animal and food production business, partially offset by higher broad-based pricing. Demand in the dairy industry is significantly reduced due to low dairy farm profitability.

SPD income before income taxes was $15.5 in the second quarter of 2019, a decrease of $0.1 as compared to the same period in 2018 due to unfavorable manufacturing costs of $4.6, higher other SG&A costs of $2.3, and lower sales volumes of $2.0, partially offset by the reversal of a $7.3 contingent consideration liability associated with the Passport acquisition, favorable price/product mix of $1.0, and lower marketing costs of $0.3. SPD income before income taxes was $27.8 in the first six months of 2019, an increase of $0.6 as compared to the same period in 2018 due primarily to the reversal of a $7.3 contingent consideration liability associated with the Passport acquisition, favorable price/product mix of $1.2, and lower marketing costs of $0.4, partially offset by higher other SG&A costs of $3.3, unfavorable manufacturing costs of $3.0 and lower sales volumes of $2.5.

### Corporate

The Corporate segment includes equity in earnings of affiliates from Armand and ArmaKleen in the second quarter of 2019 and 2018. The Corporate segment income before income taxes was $1.7 in the second quarter of 2019, as compared to $2.4 in the same period in 2018. The Corporate segment income before income taxes was $3.4 for the first six months of 2019, as compared to $4.5 in the same period in 2018.

### Liquidity and Capital Resources

On May 1, 2019, we amended our $1,000.0 unsecured revolving credit facility (the “Credit Agreement”) to extend the term of the Credit Agreement from March 29, 2023 to March 29, 2024. Under the Credit Agreement, we continue to have the ability to increase our borrowing up to an additional $600.0, subject to lender commitments and certain conditions as described in the Credit Agreement. Borrowings under the Credit Agreement are available for general corporate purposes and are used to support our $1,000.0 commercial paper program.

On May 1, 2019, we entered into a $300.0 unsecured term loan credit facility with various banks, the proceeds of which were used to partially fund the Flawless Acquisition. Unless prepaid, the loan is due on May 1, 2022. The interest rate is LIBOR plus an applicable margin based on our credit rating, which can range from 60 bps to 113 bps.

As of June 30, 2019, we had $97.9 in cash and cash equivalents, and approximately $886.9 available through the revolving facility under our Credit Agreement and our commercial paper program. To preserve our liquidity, we invest cash primarily in government money market funds, prime money market funds, short-term commercial paper and short-term bank deposits.

We repatriate excess cash held at our foreign subsidiaries. We repatriated approximately $13.0 during the second quarter of 2019 and $28.0 during the first six months of 2019. As of June 30, 2019, there is $47.0 of cash and cash equivalents held at foreign subsidiaries.

The current economic environment presents risks that could have adverse consequences for our liquidity. See “Unfavorable economic conditions could adversely affect demand for our products” under “Risk Factors” in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the “Form 10-K”). We do not anticipate that current economic conditions will adversely affect our ability to comply with the financial covenant in the Credit Agreement because we currently are, and anticipate that we will continue to be, in compliance with the maximum leverage ratio requirement under the Credit Agreement.

On February 5, 2019, the Board declared a 5% increase in the regular quarterly dividend from $0.2175 to $0.2275 per share, equivalent to an annual dividend of $0.91 per share. The increase raises the annual dividend payout from $213.3 to approximately $225.0.

In connection with the evergreen repurchase program, in January 2019, we executed open market purchases of $100.0 of our Common Stock.

We anticipate that our cash from operations, together with our current borrowing capacity, will be sufficient to meet our capital expenditure program costs, which are expected to be approximately $85.0 in 2019, fund our share repurchase programs to the extent implemented by management, pay the upcoming maturing notes and pay dividends at the latest approved rate. Cash, together with our current borrowing capacity, may be used for acquisitions that would complement our existing product lines or geographic markets. We did not have any mandatory fixed rate debt principal payments in 2018. We paid the $300.0 Floating Rate Senior Notes that matured on January 25, 2019 with cash on hand and commercial paper. The $300.0 Senior Notes (2.45%) will mature on December 15, 2019 and we currently intend to repay these notes with cash on hand and commercial paper borrowing if necessary.

#### Cash Flow Analysis

|  | Six Months Ended June 30, 2019 | June 30, 2018 |
| --- | ---: | ---: |
| Net cash provided by operating activities | **$351.2** | $322.7 |
| Net cash used in investing activities | **$(502.4)** | $(71.2) |
| Net cash used in financing activities | **$(67.7)** | $(439.5) |

**Net Cash Provided by Operating Activities –** Our primary source of liquidity is the cash flow provided by operating activities, which is dependent on net income and changes in working capital. Our net cash provided by operating activities in the six months ended June 30, 2019 increased by $28.5 to $351.2 as compared to $322.7 in the same period in 2018 due to higher cash earnings (net income plus non-cash expenses such as depreciation, amortization, and non-cash compensation) partially offset by an increase in working capital. The change in working capital is primarily due to a larger increase in accounts receivable due to the timing of sales and a smaller increase in accounts payable and accrued expenses due to higher incentive compensation and profit sharing payments partially offset by our continued program to extend payment terms with our suppliers. However, we measure working capital effectiveness based on our cash conversion cycle. The following table presents our cash conversion cycle information for the quarters ended June 30, 2019 and 2018:

|  | As of June 30, 2019 | June 30, 2018 | Change |
| --- | ---: | ---: | ---: |
| Days of sales outstanding in accounts receivable ("DSO") | 32 | 32 | 0 |
| Days of inventory outstanding ("DIO") | 60 | 57 | 3 |
| Days of accounts payable outstanding ("DPO") | 68 | 65 | (3) |
| Cash conversion cycle | 24 | 24 | 0 |

27

Our cash conversion cycle (defined as the sum of DSO and DIO less DPO) which is calculated using a two period average method, remained consistent compared to the same period in 2018. DIO increased three days from 57 to 60 days, DPO increased three days from 65 to 68 days and DSO remained consistent compared to the same period in 2018. We continue to focus on reducing our working capital requirements.

**Net Cash Used in Investing Activities –** Net cash used in investing activities during the first six months of 2019 was $502.4, primarily reflecting $475.0 for the Flawless acquisition, and $23.6 for property, plant and equipment additions. Net cash used in investing activities during the first six months of 2018 was $71.2, primarily reflecting $49.8 for the Passport Acquisition, and $19.6 for property, plant and equipment additions.

**Net Cash Used in Financing Activities –** Net cash used in financing activities during the first six months of 2019 was $67.7, reflecting $100.0 of repurchases of our common stock (“Common Stock”), $112.0 of cash dividend payments, partially offset by $109.8 of net debt borrowings and $37.0 of proceeds from stock option exercises. Net cash used in financing activities during the first six months of 2018 was $439.5, reflecting $200.0 of repurchases of our common stock (“Common Stock”), $106.2 of cash dividend payments, $159.8 of debt payments, partially offset by $28.9 of proceeds from stock option exercises.

## Market risk

As filed, 282 characters.

### Market risk

For quantitative and qualitative disclosures about market risk affecting the Company, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 7A of Part II the Form 10-K. Our exposure to market risk has not changed materially since December 31, 2018.

## Controls and procedures

As filed, 5,997 characters.

a) Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures, as of the end of the period covered by this report, are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the rules and forms of the United States Securities and Exchange Commission (the “Commission”), and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

b) Change in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurring during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

### CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION

This report contains forward-looking statements, including, among others, statements relating to net sales and earnings growth; gross margin changes; trade and marketing spending; marketing expense as a percentage of net sales; sufficiency of cash flows from operations; earnings per share; the impact of new accounting pronouncements; cost savings programs; consumer demand and spending; the effects of competition; the effect of product mix; volume growth, including the effects of new product launches into new and existing categories; the increase in the number of gummy dietary supplement competitors; the Company’s hedge programs; the impact of foreign exchange, tariffs, and commodity price fluctuations; impairments and other charges; the Company’s investments in joint ventures; the impact of acquisitions and divestitures (and any related earn-out estimates); capital expenditures; the Company’s effective tax rate; the impact of the Tax Cuts and Jobs Act; the impact of tax audits; tax changes and the lapse of applicable statutes of limitations; the effect of the credit environment on the Company’s liquidity and capital resources; the Company’s fixed rate debt and the repayment of outstanding notes as they become due; compliance with covenants under the Company’s debt instruments; the Company’s commercial paper program; the Company’s current and anticipated future borrowing capacity to meet capital expenditure program costs; and the Company’s share repurchase programs; payment of dividends; environmental and regulatory matters; the availability and adequacy of raw materials, including trona reserves and the conversion of such reserves; and the customers and consumer acceptance of certain ingredients in our products. These statements represent the intentions, plans, expectations and beliefs of the Company, and are based on assumptions that the Company believes are reasonable but may prove to be incorrect. In addition, these statements are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that could cause such differences include a decline in market growth, retailer distribution and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events); unanticipated increases in raw material and energy prices; delays or other problems in manufacturing or distribution; adverse developments affecting the financial condition of major customers and suppliers; competition; changes in marketing and promotional spending; growth or declines in various product categories and the impact of customer actions in response to changes in consumer demand and the economy, including increasing shelf space of private label products; consumer and competitor reaction to, and customer acceptance of, new product introductions and features; the Company’s ability to maintain product quality and characteristics at a level acceptable to our customers and consumers; disruptions in the banking system and financial markets; foreign currency exchange rate fluctuations; implications of the United Kingdom’s withdrawal from the European Union; shifting economic policies in the United States; potential changes in export/import and trade laws, regulations and policies of the United States and other countries, including any increased trade restrictions or tariffs, including the actual and potential effect of tariffs on Chinese goods imposed by the United States; issues relating to the Company’s information technology and controls; the impact of natural disasters on the Company and its customers and suppliers, including third party information technology service providers; the acquisition or divestiture of assets; the outcome of contingencies, including litigation, pending regulatory proceedings and environmental matters; and changes in the regulatory environment.

The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the United States federal securities laws. You are advised, however, to consult any further disclosures the Company makes on related subjects in its filings with the United States Securities and Exchange Commission (the “Commission”).

## Risk factors

As filed, 252 characters.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Form 10-K, which could materially affect the Company’s business, financial condition or future results.

Filed Jul 31, 2019.
Source: SEC EDGAR, the filing index for accession 0001564590-19-027342. Last ingested by Listed: Nov 14, 2026, 21:34 ET. No prices; not investment advice.
